Abstract
After ischaemic cerebral vascular injury, efferocytosis—a process known as the efficient clearance of apoptotic cells (ACs) by various phagocytes in both physiological and pathological states—is crucial for maintaining central nervous system (CNS) homeostasis and regaining prognosis. The mechanisms of efferocytosis in ischaemic stroke and its influence on preventing inflammation progression from secondary injury were still not fully understood, despite the fact that the fundamental process of efferocytosis has been described in a series of phases, including AC recognition, phagocyte engulfment, and subsequent degradation. The genetic reprogramming of macrophages and brain-resident microglia after an ischaemic stroke has been equated by some researchers to that of the peripheral blood and brain. Based on previous studies, some molecules, such as signal transducer and activator of transcription 6 (STAT6), peroxisome proliferator-activated receptor γ (PPARG), CD300A, and sigma non-opioid intracellular receptor 1 (SIGMAR1), were discovered to be largely associated with aspects of apoptotic cell elimination and accompanying neuroinflammation, such as inflammatory cytokine release, phenotype transformation, and suppressing of antigen presentation. Exacerbated stroke outcomes are brought on by defective efferocytosis and improper modulation of pertinent signalling pathways in blood-borne macrophages and brain microglia, which also results in subsequent tissue inflammatory damage. This review focuses on recent researches which contain a number of recently discovered mechanisms, such as studies on the relationship between benign efferocytosis and the regulation of inflammation in ischaemic stroke, the roles of some risk factors in disease progression, and current immune approaches that aim to promote efferocytosis to treat some autoimmune diseases. Understanding these pathways provides insight into novel pathophysiological processes and fresh characteristics, which can be used to build cerebral ischaemia targeting techniques.
Similar content being viewed by others
Data Availability
Not applicable.
References
Walter K (2022) What is acute ischemic stroke? JAMA 327:885
Parvez S, Kaushik M, Ali M, Alam MM, Ali J, Tabassum H et al (2022) Dodging blood brain barrier with “nano” warriors: novel strategy against ischemic stroke. Theranostics 12:689–719
Wang L, Zhu T, Xu HB, Pu XP, Zhao X, Tian F et al (2021) Effects of notoginseng leaf triterpenes on small molecule metabolism after cerebral ischemia/reperfusion injury assessed using MALDI-MS imaging. Ann Transl Med 9:246
Yu H, Chen X, Guo X, Chen D, Jiang L, Qi Y et al (2023) The clinical value of serum xanthine oxidase levels in patients with acute ischemic stroke. Redox Biol 60:102623
Nakahashi-Oda C, Fujiyama S, Nakazawa Y, Kanemaru K, Wang Y, Lyu W et al (2021) CD300a blockade enhances efferocytosis by infiltrating myeloid cells and ameliorates neuronal deficit after ischemic stroke. Sci Immunol 6:eabe7915
An C, Shi Y, Li P, Hu X, Gan Y, Stetler RA et al (2014) Molecular dialogs between the ischemic brain and the peripheral immune system: dualistic roles in injury and repair. Prog Neurobiol 115:6–24
Cai W, Dai X, Chen J, Zhao J, Xu M, Zhang L et al (2019) STAT6/Arg1 promotes microglia/macrophage efferocytosis and inflammation resolution in stroke mice. JCI Insight 4(20):e131355
Jian Z, Liu R, Zhu X, Smerin D, Zhong Y, Gu L et al (2019) The involvement and therapy target of immune cells after ischemic stroke. Front Immunol 10:2167
Wang R, Liu Y, Ye Q, Hassan SH, Zhao J, Li S et al (2020) RNA sequencing reveals novel macrophage transcriptome favoring neurovascular plasticity after ischemic stroke. J Cereb Blood Flow Metab 40:720–738
Boada-Romero E, Martinez J, Heckmann BL, Green DR (2020) The clearance of dead cells by efferocytosis. Nat Rev Mol Cell Biol 21:398–414
Doran AC, Yurdagul A Jr, Tabas I (2020) Efferocytosis in health and disease. Nat Rev Immunol 20:254–267
Arandjelovic S, Ravichandran KS (2015) Phagocytosis of apoptotic cells in homeostasis. Nat Immunol 16:907–917
Patel AR, Ritzel R, McCullough LD, Liu F (2013) Microglia and ischemic stroke: a double-edged sword. Int J Physiol Pathophysiol Pharmacol 5:73–90
García-Culebras A, Durán-Laforet V, Peña-Martínez C, Ballesteros I, Pradillo JM, Díaz-Guzmán J et al (2018) Myeloid cells as therapeutic targets in neuroinflammation after stroke: specific roles of neutrophils and neutrophil-platelet interactions. J Cereb Blood Flow Metab 38:2150–2164
Sharma M, Schlegel MP, Afonso MS, Brown EJ, Rahman K, Weinstock A et al (2020) Regulatory T cells license macrophage pro-resolving functions during atherosclerosis regression. Circ Res 127:335–353
Zhang J, Ding W, Zhao M, Liu J, Xu Y, Wan J et al (2022) Mechanisms of efferocytosis in determining inflammation resolution: therapeutic potential and the association with cardiovascular disease. Br J Pharmacol 179:5151–5171
Mehrotra P, Ravichandran KS (2022) Drugging the efferocytosis process: concepts and opportunities. Nat Rev Drug Discov 21:601–620
Zhao J, Zhang W, Wu T, Wang H, Mao J, Liu J et al (2021) Efferocytosis in the central nervous system. Front Cell Dev Biol 9:773344
Lauber K, Bohn E, Kröber SM, Xiao YJ, Blumenthal SG, Lindemann RK et al (2003) Apoptotic cells induce migration of phagocytes via caspase-3-mediated release of a lipid attraction signal. Cell 113:717–730
Truman LA, Ford CA, Pasikowska M, Pound JD, Wilkinson SJ, Dumitriu IE et al (2008) CX3CL1/fractalkine is released from apoptotic lymphocytes to stimulate macrophage chemotaxis. Blood 112:5026–5036
Gude DR, Alvarez SE, Paugh SW, Mitra P, Yu J, Griffiths R et al (2008) Apoptosis induces expression of sphingosine kinase 1 to release sphingosine-1-phosphate as a “come-and-get-me” signal. Faseb j 22:2629–2638
Chekeni FB, Elliott MR, Sandilos JK, Walk SF, Kinchen JM, Lazarowski ER et al (2010) Pannexin 1 channels mediate ‘find-me’ signal release and membrane permeability during apoptosis. Nature 467:863–867
Marques-da-Silva C, Burnstock G, Ojcius DM, Coutinho-Silva R (2011) Purinergic receptor agonists modulate phagocytosis and clearance of apoptotic cells in macrophages. Immunobiology 216:1–11
Lutz SE, González-Fernández E, Ventura JC, Pérez-Samartín A, Tarassishin L, Negoro H et al (2013) Contribution of pannexin1 to experimental autoimmune encephalomyelitis. PLoS ONE 8:e66657
Elliott MR, Ravichandran KS (2016) The Dynamics of Apoptotic Cell Clearance. Dev Cell 38:147–160
Kelley SM, Ravichandran KS (2021) Putting the brakes on phagocytosis: “don’t-eat-me” signaling in physiology and disease. EMBO Rep 22:e52564
Segawa K, Yanagihashi Y, Yamada K, Suzuki C, Uchiyama Y, Nagata S (2018) Phospholipid flippases enable precursor B cells to flee engulfment by macrophages. Proc Natl Acad Sci U S A 115:12212–12217
Brelstaff J, Tolkovsky AM, Ghetti B, Goedert M, Spillantini MG (2018) Living neurons with tau filaments aberrantly expose phosphatidylserine and are phagocytosed by microglia. Cell Rep 24:1939–48.e4
Park D, Tosello-Trampont AC, Elliott MR, Lu M, Haney LB, Ma Z et al (2007) BAI1 is an engulfment receptor for apoptotic cells upstream of the ELMO/Dock180/Rac module. Nature 450:430–434
Park D, Hochreiter-Hufford A, Ravichandran KS (2009) The phosphatidylserine receptor TIM-4 does not mediate direct signaling. Curr Biol 19:346–351
Kourtzelis I, Li X, Mitroulis I, Grosser D, Kajikawa T, Wang B et al (2019) DEL-1 promotes macrophage efferocytosis and clearance of inflammation. Nat Immunol 20:40–49
Bradley CA (2019) CD24 - a novel ‘don’t eat me’ signal. Nat Rev Cancer 19:541
Gardai SJ, Bratton DL, Ogden CA, Henson PM (2006) Recognition ligands on apoptotic cells: a perspective. J Leukoc Biol 79:896–903
Poon IK, Lucas CD, Rossi AG, Ravichandran KS (2014) Apoptotic cell clearance: basic biology and therapeutic potential. Nat Rev Immunol 14:166–180
Barkal AA, Weiskopf K, Kao KS, Gordon SR, Rosental B, Yiu YY et al (2018) Engagement of MHC class I by the inhibitory receptor LILRB1 suppresses macrophages and is a target of cancer immunotherapy. Nat Immunol 19:76–84
Elward K, Griffiths M, Mizuno M, Harris CL, Neal JW, Morgan BP et al (2005) CD46 plays a key role in tailoring innate immune recognition of apoptotic and necrotic cells. J Biol Chem 280:36342–36354
Ma Z, Thomas KS, Webb DJ, Moravec R, Salicioni AM, Mars WM et al (2002) Regulation of Rac1 activation by the low density lipoprotein receptor-related protein. J Cell Biol 159:1061–1070
Ravichandran KS, Lorenz U (2007) Engulfment of apoptotic cells: signals for a good meal. Nat Rev Immunol 7:964–974
Samejima K, Earnshaw WC (2005) Trashing the genome: the role of nucleases during apoptosis. Nat Rev Mol Cell Biol 6:677–688
Aderem A (2002) How to eat something bigger than your head. Cell 110:5–8
Becker T, Volchuk A, Rothman JE (2005) Differential use of endoplasmic reticulum membrane for phagocytosis in J774 macrophages. Proc Natl Acad Sci U S A 102:4022–4026
Campbell-Valois FX, Trost M, Chemali M, Dill BD, Laplante A, Duclos S et al (2012) Quantitative proteomics reveals that only a subset of the endoplasmic reticulum contributes to the phagosome. Mol Cell Proteomics 11:M111.016378
Wang Y, Subramanian M, Yurdagul A Jr, Barbosa-Lorenzi VC, Cai B, de Juan-Sanz J et al (2017) Mitochondrial fission promotes the continued clearance of apoptotic cells by macrophages. Cell 171:331–45.e22
Czibener C, Sherer NM, Becker SM, Pypaert M, Hui E, Chapman ER et al (2006) Ca2+ and synaptotagmin VII-dependent delivery of lysosomal membrane to nascent phagosomes. J Cell Biol 174:997–1007
Yin C, Kim Y, Argintaru D, Heit B (2016) Rab17 mediates differential antigen sorting following efferocytosis and phagocytosis. Cell Death Dis 7:e2529
Yin C, Heit B (2021) Cellular responses to the efferocytosis of apoptotic cells. Front Immunol 12:631714
Yan Q, Lin M, Huang W, Teymournejad O, Johnson JM, Hays FA et al (2018) Ehrlichia type IV secretion system effector Etf-2 binds to active RAB5 and delays endosome maturation. Proc Natl Acad Sci U S A 115:E8977–E8986
Harrison RE, Bucci C, Vieira OV, Schroer TA, Grinstein S (2003) Phagosomes fuse with late endosomes and/or lysosomes by extension of membrane protrusions along microtubules: role of Rab7 and RILP. Mol Cell Biol 23:6494–6506
Heckmann BL, Green DR (2019) Correction: LC3-associated phagocytosis at a glance. J Cell Sci 132(5):jcs222984
Martinez J, Malireddi RK, Lu Q, Cunha LD, Pelletier S, Gingras S et al (2015) Molecular characterization of LC3-associated phagocytosis reveals distinct roles for Rubicon, NOX2 and autophagy proteins. Nat Cell Biol 17:893–906
Fernández ÁF, López-Otín C (2015) The functional and pathologic relevance of autophagy proteases. J Clin Invest 125:33–41
Villani A, Benjaminsen J, Moritz C, Henke K, Hartmann J, Norlin N et al (2019) Clearance by microglia depends on packaging of phagosomes into a unique cellular compartment. Dev Cell 49:77-88.e7
Lin W, Shen P, Song Y, Huang Y, Tu S (2021) Reactive oxygen species in autoimmune cells: function, differentiation, and metabolism. Front Immunol 12:635021
Cui D, Thorp E, Li Y, Wang N, Yvan-Charvet L, Tall AR et al (2007) Pivotal advance: macrophages become resistant to cholesterol-induced death after phagocytosis of apoptotic cells. J Leukoc Biol 82:1040–1050
Kiss RS, Elliott MR, Ma Z, Marcel YL, Ravichandran KS (2006) Apoptotic cells induce a phosphatidylserine-dependent homeostatic response from phagocytes. Curr Biol 16:2252–2258
Xian X, Ding Y, Dieckmann M, Zhou L, Plattner F, Liu M et al (2017) LRP1 integrates murine macrophage cholesterol homeostasis and inflammatory responses in atherosclerosis. Elife 6:e29292
Yurdagul A Jr, Subramanian M, Wang X, Crown SB, Ilkayeva OR, Darville L et al (2020) Macrophage metabolism of apoptotic cell-derived arginine promotes continual efferocytosis and resolution of injury. Cell Metab 31:518–33.e10
Morioka S, Perry JSA, Raymond MH, Medina CB, Zhu Y, Zhao L et al (2018) Efferocytosis induces a novel SLC program to promote glucose uptake and lactate release. Nature 563:714–718
Park D, Han CZ, Elliott MR, Kinchen JM, Trampont PC, Das S et al (2011) Continued clearance of apoptotic cells critically depends on the phagocyte Ucp2 protein. Nature 477:220–224
Horst AK, Tiegs G, Diehl L (2019) Contribution of macrophage efferocytosis to liver homeostasis and disease. Front Immunol 10:2670
Fox S, Ryan KA, Berger AH, Petro K, Das S, Crowe SE et al (2015) The role of C1q in recognition of apoptotic epithelial cells and inflammatory cytokine production by phagocytes during Helicobacter pylori infection. J Inflamm (Lond) 12:51
Grau A, Tabib A, Grau I, Reiner I, Mevorach D (2015) Apoptotic cells induce NF-κB and inflammasome negative signaling. PLoS ONE 10:e0122440
Xie X, Wang L, Dong S, Ge S, Zhu T (2024) Immune regulation of the gut-brain axis and lung-brain axis involved in ischemic stroke. Neural Regen Res 19:519–528
Viaud M, Ivanov S, Vujic N, Duta-Mare M, Aira LE, Barouillet T et al (2018) Lysosomal cholesterol hydrolysis couples efferocytosis to anti-inflammatory oxysterol production. Circ Res 122:1369–1384
Chistyakov DV, Astakhova AA, Goriainov SV, Sergeeva MG (2020) Comparison of PPAR ligands as modulators of resolution of inflammation, via their influence on cytokines and oxylipins release in astrocytes. Int J Mol Sci 21(24):9577
Cai B, Thorp EB, Doran AC, Subramanian M, Sansbury BE, Lin CS et al (2016) MerTK cleavage limits proresolving mediator biosynthesis and exacerbates tissue inflammation. Proc Natl Acad Sci U S A 113:6526–6531
Zhang S, Weinberg S, DeBerge M, Gainullina A, Schipma M, Kinchen JM et al (2019) Efferocytosis fuels requirements of fatty acid oxidation and the electron transport chain to polarize macrophages for tissue repair. Cell Metab 29:443–56.e5
Zhao Y, Xiong Z, Lechner EJ, Klenotic PA, Hamburg BJ, Hulver M et al (2014) Thrombospondin-1 triggers macrophage IL-10 production and promotes resolution of experimental lung injury. Mucosal Immunol 7:440–448
DeBerge M, Yeap XY, Dehn S, Zhang S, Grigoryeva L, Misener S et al (2017) MerTK cleavage on resident cardiac macrophages compromises repair after myocardial ischemia reperfusion injury. Circ Res 121:930–940
Sakhno LV, Shevela EY, Tikhonova MA, Maksimova AA, Tyrinova TV, Ostanin AA et al (2021) Efferocytosis modulates arginase-1 and tyrosine kinase Mer expression in GM-CSF-differentiated human macrophages. Bull Exp Biol Med 170:778–781
Pupjalis D, Goetsch J, Kottas DJ, Gerke V, Rescher U (2011) Annexin A1 released from apoptotic cells acts through formyl peptide receptors to dampen inflammatory monocyte activation via JAK/STAT/SOCS signalling. EMBO Mol Med 3:102–114
Rhys HI, Dell’Accio F, Pitzalis C, Moore A, Norling LV, Perretti M (2018) Neutrophil microvesicles from healthy control and rheumatoid arthritis patients prevent the inflammatory activation of macrophages. EBioMedicine 29:60–69
Li K, Chen G, Luo H, Li J, Liu A, Yang C et al (2021) MRP8/14 mediates macrophage efferocytosis through RAGE and Gas6/MFG-E8, and induces polarization via TLR4-dependent pathway. J Cell Physiol 236:1375–1390
Proto JD, Doran AC, Gusarova G, Yurdagul A Jr, Sozen E, Subramanian M et al (2018) Regulatory T cells promote macrophage efferocytosis during inflammation resolution. Immunity 49:666–77.e6
Canton J, Khezri R, Glogauer M, Grinstein S (2014) Contrasting phagosome pH regulation and maturation in human M1 and M2 macrophages. Mol Biol Cell 25:3330–3341
Korns D, Frasch SC, Fernandez-Boyanapalli R, Henson PM, Bratton DL (2011) Modulation of macrophage efferocytosis in inflammation. Front Immunol 2:57
Zhu F, Zhou Y, Jiang C, Zhang X (2015) Role of JAK-STAT signaling in maturation of phagosomes containing Staphylococcus aureus. Sci Rep 5:14854
Heo KS, Cushman HJ, Akaike M, Woo CH, Wang X, Qiu X et al (2014) ERK5 activation in macrophages promotes efferocytosis and inhibits atherosclerosis. Circulation 130:180–191
Jiang T, Zhang YD, Gao Q, Zhou JS, Zhu XC, Lu H et al (2016) TREM1 facilitates microglial phagocytosis of amyloid beta. Acta Neuropathol 132:667–683
Vergadi E, Ieronymaki E, Lyroni K, Vaporidi K, Tsatsanis C (2017) Akt signaling pathway in macrophage activation and M1/M2 polarization. J Immunol 198:1006–1014
Mondal S, Ghosh-Roy S, Loison F, Li Y, Jia Y, Harris C et al (2011) PTEN negatively regulates engulfment of apoptotic cells by modulating activation of Rac GTPase. J Immunol 187:5783–5794
Elliott MR, Koster KM, Murphy PS (2017) Efferocytosis signaling in the regulation of macrophage inflammatory responses. J Immunol 198:1387–1394
Wu T, Jia Z, Dong S, Han B, Zhang R, Liang Y et al (2019) Panax notoginseng saponins ameliorate leukocyte adherence and cerebrovascular endothelial barrier breakdown upon ischemia-reperfusion in mice. J Vasc Res 56:1–10
Nagata S, Suzuki J, Segawa K, Fujii T (2016) Exposure of phosphatidylserine on the cell surface. Cell Death Differ 23:952–961
Li F, Zhao H, Han Z, Wang R, Tao Z, Fan Z et al (2019) Xuesaitong may protect against ischemic stroke by modulating microglial phenotypes and inhibiting neuronal cell apoptosis via the STAT3 signaling pathway. CNS Neurol Disord Drug Targets 18:115–123
Niizuma K, Tahara-Hanaoka S, Noguchi E, Shibuya A (2015) Identification and characterization of CD300H, a new member of the human CD300 immunoreceptor family. J Biol Chem 290:22298–22308
Yotsumoto K, Okoshi Y, Shibuya K, Yamazaki S, Tahara-Hanaoka S, Honda S et al (2003) Paired activating and inhibitory immunoglobulin-like receptors, MAIR-I and MAIR-II, regulate mast cell and macrophage activation. J Exp Med 198:223–233
Okoshi Y, Tahara-Hanaoka S, Nakahashi C, Honda S, Miyamoto A, Kojima H et al (2005) Requirement of the tyrosines at residues 258 and 270 of MAIR-I in inhibitory effect on degranulation from basophilic leukemia RBL-2H3. Int Immunol 17:65–72
Goemaere J, Knoops B (2012) Peroxiredoxin distribution in the mouse brain with emphasis on neuronal populations affected in neurodegenerative disorders. J Comp Neurol 520:258–280
Simhadri VR, Andersen JF, Calvo E, Choi SC, Coligan JE, Borrego F (2012) Human CD300a binds to phosphatidylethanolamine and phosphatidylserine, and modulates the phagocytosis of dead cells. Blood 119:2799–2809
Murakami Y, Tian L, Voss OH, Margulies DH, Krzewski K, Coligan JE (2014) CD300b regulates the phagocytosis of apoptotic cells via phosphatidylserine recognition. Cell Death Differ 21:1746–1757
Pluvinage JV, Haney MS, Smith BAH, Sun J, Iram T, Bonanno L et al (2019) CD22 blockade restores homeostatic microglial phagocytosis in ageing brains. Nature 568:187–192
Chen J, Zhong MC, Guo H, Davidson D, Mishel S, Lu Y et al (2017) SLAMF7 is critical for phagocytosis of haematopoietic tumour cells via Mac-1 integrin. Nature 544:493–497
Stuart LM (2005) Ezekowitz RA. Phagocytosis: elegant complexity. Immunity 22:539–550
Keren-Shaul H, Spinrad A, Weiner A, Matcovitch-Natan O, Dvir-Szternfeld R, Ulland TK et al (2017) A unique microglia type associated with restricting development of Alzheimer’s disease. Cell 169:1276–90.e17
Jia J, Cheng J, Wang C, Zhen X (2018) Sigma-1 receptor-modulated neuroinflammation in neurological diseases. Front Cell Neurosci 12:314
Wang M, Wan C, He T, Han C, Zhu K, Waddington JL et al (2021) Sigma-1 receptor regulates mitophagy in dopaminergic neurons and contributes to dopaminergic protection. Neuropharmacology 196:108360
Chen J, Li G, Qin P, Chen J, Ye N, Waddington JL et al (2022) Allosteric modulation of the sigma-1 receptor elicits antipsychotic-like effects. Schizophr Bull 48:474–484
Zhang G, Li Q, Tao W, Qin P, Chen J, Yang H et al (2023) Sigma-1 receptor-regulated efferocytosis by infiltrating circulating macrophages/microglial cells protects against neuronal impairments and promotes functional recovery in cerebral ischemic stroke. Theranostics 13:543–559
Natsvlishvili N, Goguadze N, Zhuravliova E, Mikeladze D (2015) Sigma-1 receptor directly interacts with Rac1-GTPase in the brain mitochondria. BMC Biochem 16:11
Jung JE, Karatas H, Liu Y, Yalcin A, Montaner J, Lo EH et al (2015) STAT-dependent upregulation of 12/15-lipoxygenase contributes to neuronal injury after stroke. J Cereb Blood Flow Metab 35:2043–2051
Bushnell CD, Chaturvedi S, Gage KR, Herson PS, Hurn PD, Jiménez MC et al (2018) Sex differences in stroke: challenges and opportunities. J Cereb Blood Flow Metab 38:2179–2191
Truettner JS, Bramlett HM, Dietrich WD (2017) Posttraumatic therapeutic hypothermia alters microglial and macrophage polarization toward a beneficial phenotype. J Cereb Blood Flow Metab 37:2952–2962
Hu X, Li P, Guo Y, Wang H, Leak RK, Chen S et al (2012) Microglia/macrophage polarization dynamics reveal novel mechanism of injury expansion after focal cerebral ischemia. Stroke 43:3063–3070
Fenn AM, Hall JC, Gensel JC, Popovich PG, Godbout JP (2014) IL-4 signaling drives a unique arginase+/IL-1β+ microglia phenotype and recruits macrophages to the inflammatory CNS: consequences of age-related deficits in IL-4Rα after traumatic spinal cord injury. J Neurosci 34:8904–8917
Zhang W, Zhao J, Wang R, Jiang M, Ye Q, Smith AD et al (2019) Macrophages reprogram after ischemic stroke and promote efferocytosis and inflammation resolution in the mouse brain. CNS Neurosci Ther 25:1329–1342
Nepal S, Tiruppathi C, Tsukasaki Y, Farahany J, Mittal M, Rehman J et al (2019) STAT6 induces expression of Gas6 in macrophages to clear apoptotic neutrophils and resolve inflammation. Proc Natl Acad Sci U S A 116:16513–16518
Seneviratne AN, Edsfeldt A, Cole JE, Kassiteridi C, Swart M, Park I et al (2017) Interferon regulatory factor 5 controls necrotic core formation in atherosclerotic lesions by impairing efferocytosis. Circulation 136:1140–1154
Szanto A, Balint BL, Nagy ZS, Barta E, Dezso B, Pap A et al (2010) STAT6 transcription factor is a facilitator of the nuclear receptor PPARγ-regulated gene expression in macrophages and dendritic cells. Immunity 33:699–712
Zhao XR, Gonzales N, Aronowski J (2015) Pleiotropic role of PPARγ in intracerebral hemorrhage: an intricate system involving Nrf2, RXR, and NF-κB. CNS Neurosci Ther 21:357–366
Cherry JD, Olschowka JA, O’Banion MK (2014) Neuroinflammation and M2 microglia: the good, the bad, and the inflamed. J Neuroinflammation 11:98
Quirié A, Demougeot C, Bertrand N, Mossiat C, Garnier P, Marie C et al (2013) Effect of stroke on arginase expression and localization in the rat brain. Eur J Neurosci 37:1193–1202
Zhu J, Guo L, Watson CJ, Hu-Li J, Paul WE (2001) Stat6 is necessary and sufficient for IL-4’s role in Th2 differentiation and cell expansion. J Immunol 166:7276–7281
Nakahashi-Oda C, Tahara-Hanaoka S, Honda S, Shibuya K, Shibuya A (2012) Identification of phosphatidylserine as a ligand for the CD300a immunoreceptor. Biochem Biophys Res Commun 417:646–650
Lambertsen KL, Clausen BH, Babcock AA, Gregersen R, Fenger C, Nielsen HH et al (2009) Microglia protect neurons against ischemia by synthesis of tumor necrosis factor. J Neurosci 29:1319–1330
Zaremba J, Losy J (2001) Early TNF-alpha levels correlate with ischaemic stroke severity. Acta Neurol Scand 104:288–295
Chu HX, Broughton BR, Kim HA, Lee S, Drummond GR, Sobey CG (2015) Evidence that Ly6C(hi) monocytes are protective in acute ischemic stroke by promoting M2 macrophage polarization. Stroke 46:1929–1937
Lim JJ, Grinstein S, Roth Z (2017) Diversity and versatility of phagocytosis: roles in innate immunity, tissue remodeling, and homeostasis. Front Cell Infect Microbiol 7:191
Moreno JL, Mikhailenko I, Tondravi MM, Keegan AD (2007) IL-4 promotes the formation of multinucleated giant cells from macrophage precursors by a STAT6-dependent, homotypic mechanism: contribution of E-cadherin. J Leukoc Biol 82:1542–1553
Wang Z, Kawabori M, Houkin K (2020) FTY720 (fingolimod) ameliorates brain injury through multiple mechanisms and is a strong candidate for stroke treatment. Curr Med Chem 27:2979–2993
Rollini F, Franchi F, Angiolillo DJ (2017) Drug-drug interactions when switching between intravenous and oral P2Y(12) receptor inhibitors: how real is it? JACC Cardiovasc Interv 10:130–132
Kansakar U, Gambardella J, Varzideh F, Avvisato R, Jankauskas SS, Mone P et al (2022) miR-142 targets TIM-1 in human endothelial cells: potential implications for stroke, COVID-19, Zika, Ebola, dengue, and other viral infections. Int J Mol Sci 23(18):10242
Zheng L, Jia J, Chen Y, Liu R, Cao R, Duan M et al (2022) Pentoxifylline alleviates ischemic white matter injury through up-regulating Mertk-mediated myelin clearance. J Neuroinflammation 19:128
Palakurti R, Biswas N, Roy S, Gnyawali SC, Sinha M, Singh K et al (2023) Inducible miR-1224 silences cerebrovascular Serpine1 and restores blood flow to the stroke-affected site of the brain. Mol Ther Nucleic Acids 31:276–292
Qin Y, He Y, Zhu YM, Li M, Ni Y, Liu J et al (2019) CID1067700, a late endosome GTPase Rab7 receptor antagonist, attenuates brain atrophy, improves neurologic deficits and inhibits reactive astrogliosis in rat ischemic stroke. Acta Pharmacol Sin 40:724–736
Fu C, Wu Y, Liu S, Luo C, Lu Y, Liu M et al (2022) Rehmannioside A improves cognitive impairment and alleviates ferroptosis via activating PI3K/AKT/Nrf2 and SLC7A11/GPX4 signaling pathway after ischemia. J Ethnopharmacol 289:115021
Xian M, Cai J, Zheng K, Liu Q, Liu Y, Lin H et al (2021) Aloe-emodin prevents nerve injury and neuroinflammation caused by ischemic stroke via the PI3K/AKT/mTOR and NF-κB pathway. Food Funct 12:8056–8067
Wang HJ, Ran HF, Yin Y, Xu XG, Jiang BX, Yu SQ et al (2022) Catalpol improves impaired neurovascular unit in ischemic stroke rats via enhancing VEGF-PI3K/AKT and VEGF-MEK1/2/ERK1/2 signaling. Acta Pharmacol Sin 43:1670–1685
Li R, Zheng Y, Zhang J, Zhou Y, Fan X (2023) Gomisin N attenuated cerebral ischemia-reperfusion injury through inhibition of autophagy by activating the PI3K/AKT/mTOR pathway. Phytomedicine 110:154644
Zhou Z, Xu N, Matei N, McBride DW, Ding Y, Liang H et al (2021) Sodium butyrate attenuated neuronal apoptosis via GPR41/Gβγ/PI3K/Akt pathway after MCAO in rats. J Cereb Blood Flow Metab 41:267–281
Cai J, Liang J, Zhang Y, Shen L, Lin H, Hu T et al (2022) Cyclo-(Phe-Tyr) as a novel cyclic dipeptide compound alleviates ischemic/reperfusion brain injury via JUNB/JNK/NF-κB and SOX5/PI3K/AKT pathways. Pharmacol Res 180:106230
Du Q, Deng R, Li W, Zhang D, Tsoi B, Shen J (2021) Baoyuan Capsule promotes neurogenesis and neurological functional recovery through improving mitochondrial function and modulating PI3K/Akt signaling pathway. Phytomedicine 93:153795
Lu T, Li H, Zhou Y, Wei W, Ding L, Zhan Z et al (2022) Neuroprotective effects of alisol A 24-acetate on cerebral ischaemia-reperfusion injury are mediated by regulating the PI3K/AKT pathway. J Neuroinflammation 19:37
Li R, Zheng Y, Zhang J, Zhou Y, Fan X (2023) Gomisin N attenuated cerebral ischemia-reperfusion injury through inhibition of autophagy by activating the PI3K/AKT/mTOR pathway. Phytomedicine 110:154644
Li R, Zhao K, Ruan Q, Meng C, Yin F (2020) Bone marrow mesenchymal stem cell-derived exosomal microRNA-124-3p attenuates neurological damage in spinal cord ischemia-reperfusion injury by downregulating Ern1 and promoting M2 macrophage polarization. Arthritis Res Ther 22:75
Chen HL, Yang L, Zhang XL, Jia QY, Duan ZD, Li JJ et al (2023) Scutellarin acts via MAPKs pathway to promote M2 polarization of microglial cells. Mol Neurobiol 60(8):4304–4323
Shin JA, Lim SM, Jeong SI, Kang JL, Park EM (2014) Noggin improves ischemic brain tissue repair and promotes alternative activation of microglia in mice. Brain Behav Immun 40:143–154
Zheng K, Zhang Y, Zhang C, Ye W, Ye C, Tan X et al (2022) PRMT8 attenuates cerebral ischemia/reperfusion injury via modulating microglia activation and polarization to suppress neuroinflammation by upregulating Lin28a. ACS Chem Neurosci 13:1096–1104
Zhang Z, Wang Q, Zhao X, Shao L, Liu G, Zheng X et al (2020) YTHDC1 mitigates ischemic stroke by promoting Akt phosphorylation through destabilizing PTEN mRNA. Cell Death Dis 11:977
Pan R, Xie Y, Fang W, Liu Y, Zhang Y (2022) USP20 mitigates ischemic stroke in mice by suppressing neuroinflammation and neuron death via regulating PTEN signal. Int Immunopharmacol 103:107840
Zhang ZF, Chen J, Han X, Zhang Y, Liao HB, Lei RX et al (2017) Bisperoxovandium (pyridin-2-squaramide) targets both PTEN and ERK1/2 to confer neuroprotection. Br J Pharmacol 174:641–656
Zheng T, Shi Y, Zhang J, Peng J, Zhang X, Chen K et al (2019) MiR-130a exerts neuroprotective effects against ischemic stroke through PTEN/PI3K/AKT pathway. Biomed Pharmacother 117:109117
Pan J, Jin JL, Ge HM, Yin KL, Chen X, Han LJ et al (2015) Malibatol A regulates microglia M1/M2 polarization in experimental stroke in a PPARγ-dependent manner. J Neuroinflammation 12:51
Liu C, Wu C, Yang Q, Gao J, Li L, Yang D et al (2016) Macrophages mediate the repair of brain vascular rupture through direct physical adhesion and mechanical traction. Immunity 44:1162–1176
Werner Y, Mass E, Ashok Kumar P, Ulas T, Händler K, Horne A et al (2020) Cxcr4 distinguishes HSC-derived monocytes from microglia and reveals monocyte immune responses to experimental stroke. Nat Neurosci 23:351–362
Huang Z, Huang PL, Panahian N, Dalkara T, Fishman MC, Moskowitz MA (1994) Effects of cerebral ischemia in mice deficient in neuronal nitric oxide synthase. Science 265:1883–1885
Jacob MA, Ekker MS, Allach Y, Cai M, Aarnio K, Arauz A et al (2022) Global differences in risk factors, etiology, and outcome of ischemic stroke in young adults-a worldwide meta-analysis: the GOAL Initiative. Neurology 98:e573–e588
Diener HC, Hankey GJ (2020) Primary and secondary prevention of ischemic stroke and cerebral hemorrhage: JACC Focus Seminar. J Am Coll Cardiol 75:1804–1818
Halade GV, Lee DH (2022) Inflammation and resolution signaling in cardiac repair and heart failure. EBioMedicine 79:103992
Watso JC, Fancher IS, Gomez DH, Hutchison ZJ, Gutiérrez OM, Robinson AT (2023) The damaging duo: Obesity and excess dietary salt contribute to hypertension and cardiovascular disease. Obes Rev 24:e13589
Li X, Alu A, Wei Y, Wei X, Luo M (2022) The modulatory effect of high salt on immune cells and related diseases. Cell Prolif 55:e13250
Zhang T, Wang D, Li X, Jiang Y, Wang C, Zhang Y et al (2020) Excess salt intake promotes M1 microglia polarization via a p38/MAPK/AR-dependent pathway after cerebral ischemia in mice. Int Immunopharmacol 81:106176
Wang Y, Grainger DW (2012) RNA therapeutics targeting osteoclast-mediated excessive bone resorption. Adv Drug Deliv Rev 64:1341–1357
Maida CD, Daidone M, Pacinella G, Norrito RL, Pinto A, Tuttolomondo A (2022) Diabetes and ischemic stroke: an old and new relationship an overview of the close interaction between these diseases. Int J Mol Sci 23(4):2397
Dhindsa S, Tripathy D, Mohanty P, Ghanim H, Syed T, Aljada A et al (2004) Differential effects of glucose and alcohol on reactive oxygen species generation and intranuclear nuclear factor-kappaB in mononuclear cells. Metabolism 53:330–334
Liu X, Liu H, Deng Y (2023) Efferocytosis: an emerging therapeutic strategy for type 2 diabetes mellitus and diabetes complications. J Inflamm Res 16:2801–2815
Govindappa PK, Elfar JC (2022) Erythropoietin promotes M2 macrophage phagocytosis of Schwann cells in peripheral nerve injury. Cell Death Dis 13:245
Cai W, Hu M, Li C, Wu R, Lu D, Xie C et al (2023) FOXP3+ macrophage represses acute ischemic stroke-induced neural inflammation. Autophagy 19:1144–1163
Finger CE, Moreno-Gonzalez I, Gutierrez A, Moruno-Manchon JF, McCullough LD (2022) Age-related immune alterations and cerebrovascular inflammation. Mol Psychiatry 27:803–818
De Maeyer RPH, van de Merwe RC, Louie R, Bracken OV, Devine OP, Goldstein DR et al (2020) Blocking elevated p38 MAPK restores efferocytosis and inflammatory resolution in the elderly. Nat Immunol 21:615–625
Yang PC, Xing Z, Berin CM, Soderholm JD, Feng BS, Wu L et al (2007) TIM-4 expressed by mucosal dendritic cells plays a critical role in food antigen-specific Th2 differentiation and intestinal allergy. Gastroenterology 133:1522–1533
Joseph SB, McKilligin E, Pei L, Watson MA, Collins AR, Laffitte BA et al (2002) Synthetic LXR ligand inhibits the development of atherosclerosis in mice. Proc Natl Acad Sci U S A 99:7604–7609
Wang Y, Gao H, Huang X, Chen Z, Kang P, Zhou Y et al (2022) Cyclodextrin boostered-high density lipoprotein for antiatherosclerosis by regulating cholesterol efflux and efferocytosis. Carbohydr Polym 292:119632
Ye ZM, Yang S, Xia YP, Hu RT, Chen S, Li BW et al (2019) LncRNA MIAT sponges miR-149-5p to inhibit efferocytosis in advanced atherosclerosis through CD47 upregulation. Cell Death Dis 10:138
Mueller PA, Kojima Y, Huynh KT, Maldonado RA, Ye J, Tavori H et al (2022) Macrophage LRP1 (Low-Density Lipoprotein Receptor-Related Protein 1) Is Required for the effect of CD47 blockade on efferocytosis and atherogenesis-brief report. Arterioscler Thromb Vasc Biol 42:e1–e9
McCubbrey AL, McManus SA, McClendon JD, Thomas SM, Chatwin HB, Reisz JA et al (2022) Polyamine import and accumulation causes immunomodulation in macrophages engulfing apoptotic cells. Cell Rep 38:110222
Chang HY, Lee HN, Kim W, Surh YJ (2015) Docosahexaenoic acid induces M2 macrophage polarization through peroxisome proliferator-activated receptor γ activation. Life Sci 120:39–47
Doddapattar P, Dev R, Ghatge M, Patel RB, Jain M, Dhanesha N et al (2022) Myeloid cell PKM2 deletion enhances efferocytosis and reduces atherosclerosis. Circ Res 130:1289–1305
Jin Y, Liu Y, Xu L, Xu J, Xiong Y, Peng Y et al (2022) Novel role for caspase 1 inhibitor VX765 in suppressing NLRP3 inflammasome assembly and atherosclerosis via promoting mitophagy and efferocytosis. Cell Death Dis 13:512
Zhang J, Zhao X, Guo Y, Liu Z, Wei S, Yuan Q et al (2022) Macrophage ALDH2 (aldehyde dehydrogenase 2) stabilizing Rac2 is required for efferocytosis internalization and reduction of atherosclerosis development. Arterioscler Thromb Vasc Biol 42:700–716
Lai YS, Putra R, Aui SP, Chang KT (2018) M2(C) polarization by baicalin enhances efferocytosis via upregulation of MERTK receptor. Am J Chin Med 46:1899–1914
Morimoto K, Janssen WJ, Fessler MB, McPhillips KA, Borges VM, Bowler RP et al (2006) Lovastatin enhances clearance of apoptotic cells (efferocytosis) with implications for chronic obstructive pulmonary disease. J Immunol 176:7657–7665
Hodge S, Matthews G, Dean MM, Ahern J, Djukic M, Hodge G et al (2010) Therapeutic role for mannose-binding lectin in cigarette smoke-induced lung inflammation? Evidence from a murine model. Am J Respir Cell Mol Biol 42:235–242
Vago JP, Galvão I, Negreiros-Lima GL, Teixeira LCR, Lima KM, Sugimoto MA et al (2020) Glucocorticoid-induced leucine zipper modulates macrophage polarization and apoptotic cell clearance. Pharmacol Res 158:104842
Zhang M, Johnson-Stephenson TK, Wang W, Wang Y, Li J, Li L et al (2022) Mesenchymal stem cell-derived exosome-educated macrophages alleviate systemic lupus erythematosus by promoting efferocytosis and recruitment of IL-17(+) regulatory T cell. Stem Cell Res Ther 13:484
Caballero-García A, Córdova-Martínez A, Vicente-Salar N, Roche E, Pérez-Valdecantos D (2021) Vitamin D, its role in recovery after muscular damage following exercise. Nutrients 13(7):2336
Sós L, Garabuczi É, Sághy T, Mocsár G, Szondy Z (2022) Palmitate inhibits mouse macrophage efferocytosis by activating an mTORC1-regulated rho kinase 1 pathway: therapeutic implications for the treatment of obesity. Cells 11(21):3502
deCathelineau AM, Henson PM (2003) The final step in programmed cell death: phagocytes carry apoptotic cells to the grave. Essays Biochem 39:105–117
Iversen OH (1967) Kinetics of cellular proliferation and cell loss in human carcinomas. A discussion of methods available for in vivo studies. Eur J Cancer 3:389–94
Gregory CD (2023) Hijacking homeostasis: regulation of the tumor microenvironment by apoptosis. Immunol Rev 319(1):100–127
Savill J, Dransfield I, Gregory C, Haslett C (2002) A blast from the past: clearance of apoptotic cells regulates immune responses. Nat Rev Immunol 2:965–975
Serhan CN, Savill J (2005) Resolution of inflammation: the beginning programs the end. Nat Immunol 6:1191–1197
Huang Q, Li F, Liu X, Li W, Shi W, Liu FF et al (2011) Caspase 3-mediated stimulation of tumor cell repopulation during cancer radiotherapy. Nat Med 17:860–866
Morris RG, Hargreaves AD, Duvall E, Wyllie AH (1984) Hormone-induced cell death. 2. Surface changes in thymocytes undergoing apoptosis. Am J Pathol 115:426–36
Wu Y, Wang C, Yan Y, Hao Y, Liu B, Dong Z et al (2023) Efferocytosis nanoinhibitors to promote secondary necrosis and potentiate the immunogenicity of conventional cancer therapies for improved therapeutic benefits. ACS Nano 17:18089–18102
Chen Z, Li Z, Huang H, Shen G, Ren Y, Mao X et al (2023) Cancer immunotherapy based on cell membrane-coated nanocomposites augmenting cGAS/STING activation by efferocytosis blockade. Small 19(43):e2302758
Zhuang WR, Wang Y, Nie W, Lei Y, Liang C, He J et al (2023) Bacterial outer membrane vesicle based versatile nanosystem boosts the efferocytosis blockade triggered tumor-specific immunity. Nat Commun 14:1675
Shang Y, Lu H, Liao L, Li S, Xiong H, Yao J (2023) Bioengineered nanospores selectively blocking LC3-associated phagocytosis in tumor-associated macrophages potentiate antitumor immunity. ACS Nano 17:10872–10887
Perlman H, Pagliari LJ, Volin MV (2001) Regulation of apoptosis and cell cycle activity in rheumatoid arthritis. Curr Mol Med 1:597–608
Bonnefoy F, Daoui A, Valmary-Degano S, Toussirot E, Saas P, Perruche S (2016) Apoptotic cell infusion treats ongoing collagen-induced arthritis, even in the presence of methotrexate, and is synergic with anti-TNF therapy. Arthritis Res Ther 18:184
Elliott MR, Chekeni FB, Trampont PC, Lazarowski ER, Kadl A, Walk SF et al (2009) Nucleotides released by apoptotic cells act as a find-me signal to promote phagocytic clearance. Nature 461:282–286
da Silva JLG, Passos DF, Bernardes VM, Leal DBR (2019) ATP and adenosine: role in the immunopathogenesis of rheumatoid arthritis. Immunol Lett 214:55–64
Hasebe R, Murakami K, Harada M, Halaka N, Nakagawa H, Kawano F et al (2022) ATP spreads inflammation to other limbs through crosstalk between sensory neurons and interneurons. J Exp Med 219(6):e20212019
Schneider K, Arandjelovic S (2023) Apoptotic cell clearance components in inflammatory arthritis. Immunol Rev
Lieffrig SA, Gyimesi G, Mao Y, Finnemann SC (2023) Clearance phagocytosis by the retinal pigment epithelial during photoreceptor outer segment renewal: Molecular mechanisms and relation to retinal inflammation. Immunol Rev 319(1):81–99
Neels JG, Gollentz C, Chinetti G (2023) Macrophage death in atherosclerosis: potential role in calcification. Front Immunol 14:1215612
Kumar D, Pandit R, Yurdagul A Jr (2023) Mechanisms of continual efferocytosis by macrophages and its role in mitigating atherosclerosis. Immunometabolism (Cobham) 5:e00017
Funding
This research was supported by the National Natural Science Foundation of China (No. 82204663) and the Natural Science Foundation of Shandong Province (No. ZR2022QH058).
Author information
Authors and Affiliations
Contributions
Literature retrieval and manuscript writing: XDX; figure preparation: XDX, SSD, RJL; manuscript revision: SSD, LLS; review supervision: TZ. All authors approved the final version of the manuscript.
Corresponding author
Ethics declarations
Ethics Approval and Consent to Participate
Not applicable.
Consent for Publication
Not applicable.
Competing Interests
The authors declare no competing interests.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Xie, XD., Dong, SS., Liu, RJ. et al. Mechanism of Efferocytosis in Determining Ischaemic Stroke Resolution—Diving into Microglia/Macrophage Functions and Therapeutic Modality. Mol Neurobiol (2024). https://doi.org/10.1007/s12035-024-04060-4
Received:
Accepted:
Published:
DOI: https://doi.org/10.1007/s12035-024-04060-4